Alignment Healthcare, Inc. (ALHC)
NASDAQ: ALHC · Real-Time Price · USD
7.55
-1.17 (-13.38%)
At close: Oct 9, 2026, 4:00 PM EDT
7.43
-0.12 (-1.59%)
After-hours: Oct 9, 2026, 7:48 PM EDT
Alignment Healthcare Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, Alignment Healthcare stock has a consensus rating of "Buy" and an average price target of $17.15. The average 1-year stock price forecast is 127.30% higher than the current stock price, while the lowest is $9.00 (+19.28%) and the highest is $28 (+271.11%).
Price Target: $17.15 (+127.30%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Alignment Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 10 | 9 | 9 | 7 |
| Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Hold | 2 | 2 | 2 | 2 | 2 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 14 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Hold Downgrades $25 → $9 | Hold | Downgrades | $25 → $9 | +19.28% | Oct 9, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $22 → $10 | Buy | Maintains | $22 → $10 | +32.54% | Oct 9, 2026 |
| William Blair | William Blair | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Oct 9, 2026 |
| KeyBanc | KeyBanc | Buy Maintains $28 → $12 | Buy | Maintains | $28 → $12 | +59.05% | Oct 9, 2026 |
| Barclays | Barclays | Hold Maintains $16 → $10 | Hold | Maintains | $16 → $10 | +32.54% | Oct 6, 2026 |
Financial Forecast
Revenue This Year
5.22B
from 3.95B
Increased by 32.14%
Revenue Next Year
6.51B
from 5.22B
Increased by 24.68%
EPS This Year
0.48
from 0.32
Increased by 49.34%
EPS Next Year
0.74
from 0.48
Increased by 53.13%
EPS and Forward PE are based on non-GAAP adjusted numbers.